KCNMB4

KCNMB4 encodes the β4 auxiliary subunit of large-conductance Ca²⁺-activated K⁺ (BK/KCa1.1) channels, which assembles with the pore-forming α-subunit to produce iberiotoxin-resistant, slow-gating "type II" channels with high open probability, in contrast to fast-gating, iberiotoxin-sensitive α-only "type I" channels (PMID:29145442, PMID:12388098). By dictating BK channel subtype composition, β4 sets neuronal and epithelial excitability: seizure-induced downregulation of KCNMB4 in dentate granule neurons converts type II channels to type I and raises excitability and seizure sensitivity, and estrogen-dependent miR-504 upregulation similarly suppresses β4 in baroreceptor afferents to alter their firing (PMID:29145442, PMID:32653540). β4-containing channels carry out defined physiological roles in distinct tissues — they regulate renal potassium and sodium handling in distal nephron intercalated cells during potassium adaptation (PMID:20299355), govern aqueous humor outflow through the trabecular meshwork and Schlemm's canal (PMID:32203982), and suppress sympathetic outflow from hypothalamic paraventricular nucleus neurons, an action lost in chronic heart failure (PMID:29562421). The subunit is recruited to neuronal mitochondrial inner membranes in addition to the plasma membrane, indicating a role in mitochondrial BK channel regulation (PMID:18359571). KCNMB4 expression is controlled both post-transcriptionally by miR-504 (PMID:32653540) and transcriptionally by PRMT5-catalyzed H3R2me2s methylation at its promoter, an axis that drives paclitaxel resistance in nasopharyngeal carcinoma (PMID:41513606); a recurrent KCNMB4-CCND3 fusion that promotes cell migration occurs in osteosarcoma (PMID:25300797).

1. 2002 Medium

   Established that the β4 subunit physically assembles with the BK α-subunit to form heteromeric channels with pharmacology distinct from α homotetramers, defining its core role as a channel-modifying auxiliary subunit.

   Evidence RT-PCR, patch-clamp electrophysiology, and iberiotoxin pharmacology in mouse parotid acinar cells with β1 knockout controls

   PMID:12388098

   Open questions at the time

   • Stoichiometry of α/β4 assembly not resolved
   • Structural basis of altered iberiotoxin sensitivity not defined
2. 2003 Medium

   Linked β4-containing KCa channels to a defined upstream signaling cascade, showing they are activated downstream of metabotropic glutamate receptor signaling in astrocytes.

   Evidence RT-PCR, Northern blot, single-channel patch-clamp, and pharmacological dissection of G-protein/PLC/cytochrome P450 epoxygenase pathway in rat hippocampal astrocytes

   PMID:12629172

   Open questions at the time

   • Direct gating effect of the epoxygenase metabolite on β4-containing channels not isolated
   • β4 dependence of the response not tested by knockout
3. 2008 Medium

   Revealed an unexpected subcellular distribution, placing β4 at the inner mitochondrial membrane and implicating it in mitochondrial BK channel regulation beyond the plasma membrane.

   Evidence Western blot, immunofluorescence, and immunoelectron microscopy in rat brain and cultured neurons

   PMID:18359571

   Open questions at the time

   • Functional role of mitochondrial β4 not demonstrated
   • Mechanism of mitochondrial targeting unknown
4. 2010 High

   Defined an in vivo physiological function for β4 in renal potassium homeostasis, showing it is required for intercalated cell adaptation to potassium load.

   Evidence Kcnmb4 knockout mice with urinary/plasma electrolyte measurements, Na-K-ATPase immunohistochemistry, and morphometry

   PMID:20299355

   Open questions at the time

   • Channel-level gating changes in intercalated cells not directly recorded
   • Link between cell-size change and channel activity not mechanistically resolved
5. 2014 Medium

   Identified transcriptional/extrinsic regulators and a disease-associated rearrangement of KCNMB4, broadening it from a fixed channel subunit to a regulated, context-dependent gene.

   Evidence IFN-γ treatment with qPCR and LRRC26-dissociation pharmacology in airway epithelia (24414257); transcriptome sequencing, FISH, and migration assay identifying KCNMB4-CCND3 fusion in osteosarcoma (25300797); S-acylation and trafficking assays summarized in review (25140154)

   PMID:24414257 PMID:25140154 PMID:25300797

   Open questions at the time

   • S-acylation evidence is from a review without primary data for this subunit
   • Causal contribution of KCNMB4 loss versus LRRC26 loss to airway phenotype not separated
   • CCND3 fusion concerns a chimeric product, not native β4 function
6. 2017 High

   Provided the clearest mechanistic logic for β4 as a subtype switch, showing seizure-driven downregulation converts slow type II channels to fast type I channels and that β4 loss is sufficient to raise excitability.

   Evidence Pilocarpine seizure model with qPCR, single-channel patch-clamp, iberiotoxin pharmacology, and heterozygous Kcnmb4 knockout mice

   PMID:29145442

   Open questions at the time

   • Upstream signal driving KCNMB4 mRNA downregulation not identified
   • Generalizability of the switch to non-neuronal tissues not established
7. 2018 Medium

   Extended β4 function to autonomic control, showing PVN β4-containing channels suppress sympathetic outflow and are downregulated in chronic heart failure.

   Evidence Coronary ligation CHF model with rAAV2-shRNA knockdown, renal sympathetic nerve activity recording, echocardiography, and expression assays in rats

   PMID:29562421

   Open questions at the time

   • Mechanism driving KCNMB4 downregulation in CHF not defined
   • Direct channel recordings from PVN neurons not reported
8. 2020 Medium

   Established β4 as the predominant β-subunit governing ocular aqueous outflow and confirmed post-transcriptional control of β4 by an estrogen-driven microRNA in sensory afferents.

   Evidence qPCR, immunofluorescence, and martentoxin/iberiotoxin outflow-facility measurement in outflow tissues (32203982); miR-504 prediction, qPCR in ovariectomized vs. intact rats, and electrophysiology in nodose ganglia (32653540)

   PMID:32203982 PMID:32653540

   Open questions at the time

   • Direct miR-504 binding to the KCNMB4 3'UTR not experimentally confirmed
   • Cell type mediating outflow regulation not pinpointed
9. 2026 Medium

   Resolved a transcriptional regulatory mechanism, showing PRMT5-catalyzed H3R2me2s methylation activates KCNMB4 and that this axis confers chemoresistance.

   Evidence ChIP, H3R2me2s histone methylation assays, PRMT5 inhibition in vitro and in vivo, and paclitaxel resistance assays in nasopharyngeal carcinoma cells

   PMID:41513606

   Open questions at the time

   • How KCNMB4 expression mediates paclitaxel resistance mechanistically not defined
   • Whether channel activity versus another role drives resistance unresolved

• How the diverse regulatory inputs (S-acylation, miR-504, PRMT5/H3R2me2s, IFN-γ, disease states) are integrated to tune β4 levels in specific cell types, and the functional role of mitochondrial β4, remain unresolved.
• No unified model linking transcriptional and post-translational control of KCNMB4
• Mitochondrial BK β4 function uncharacterized
• Structural basis of α/β4 assembly and toxin selectivity not determined